215 related articles for article (PubMed ID: 34783396)
1. The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study.
Takeda K; Suzuki J; Watanabe A; Sekiguchi R; Sano T; Watanabe M; Narumoto O; Kawashima M; Fukami T; Sasaki Y; Tamura A; Nagai H; Matsui H; Kamei K
Mycoses; 2022 Feb; 65(2):164-170. PubMed ID: 34783396
[TBL] [Abstract][Full Text] [Related]
2. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.
Hagiwara S; Tamura T; Satoh K; Kamewada H; Nakano M; Shinden S; Yamaguchi H; Makimura K
Mycopathologia; 2019 Feb; 184(1):13-21. PubMed ID: 30291485
[TBL] [Abstract][Full Text] [Related]
4. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
[TBL] [Abstract][Full Text] [Related]
5. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea.
Won EJ; Shin JH; Kim SH; Choi MJ; Byun SA; Kim MN; Lee WG; Lee K; Uh Y; Shin MG; Suh SP
Med Mycol; 2018 Jun; 56(4):501-505. PubMed ID: 28992138
[TBL] [Abstract][Full Text] [Related]
7. Drug Sensitivity and Resistance Mechanism in Aspergillus Section
Hashimoto A; Hagiwara D; Watanabe A; Yahiro M; Yikelamu A; Yaguchi T; Kamei K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607016
[No Abstract] [Full Text] [Related]
8. Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings.
Takeda K; Suzuki J; Sasaki Y; Watanabe A; Kamei K
Med Mycol J; 2023; 64(4):95-98. PubMed ID: 38030277
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
[TBL] [Abstract][Full Text] [Related]
10. Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
Toyotome T; Saito S; Koshizaki Y; Komatsu R; Matsuzawa T; Yaguchi T
J Infect Chemother; 2020 Feb; 26(2):321-323. PubMed ID: 31564504
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Mello E; Posteraro B; Vella A; De Carolis E; Torelli R; D'Inzeo T; Verweij PE; Sanguinetti M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Halvaeezadeh M; Jalaee GA; Fatahinia M; Mahmoudabadi AZ
Microb Pathog; 2023 Aug; 181():106180. PubMed ID: 37257666
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
14. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
15. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of
Nargesi S; Jafarzadeh J; Najafzadeh MJ; Nouripour-Sisakht S; Haghani I; Abastabar M; Ilkit M; Hedayati MT
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451946
[No Abstract] [Full Text] [Related]
19. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
Hendrickx M; Beguin H; Detandt M
Mycoses; 2012 Mar; 55(2):148-55. PubMed ID: 21929560
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
